Medrano, Ruan Felipe; Catani, João Paulo Portela; Ribeiro, Aline Hunger; Tomaz, Samanta Lopes; Merkel, Christian A; Costanzi-Strauss, Eugenia 
; Strauss, Bryan Eric
Fonte: Cancer Immunology, Immunotherapy. Unidade: ICB
Assuntos: IMUNOTERAPIA, MELANOMA, ADENOVÍRUS, VACINAÇÃO, TRANSFERÊNCIA DE GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDRANO, Ruan Felipe et al. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy. Cancer Immunology, Immunotherapy, v. 65, n. 4, p. 371-382, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00262-016-1807-8. Acesso em: 27 jun. 2024.APA
Medrano, R. F., Catani, J. P. P., Ribeiro, A. H., Tomaz, S. L., Merkel, C. A., Costanzi-Strauss, E., & Strauss, B. E. (2016). Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy. Cancer Immunology, Immunotherapy, 65( 4), 371-382. doi:10.1007/s00262-016-1807-8NLM
Medrano RF, Catani JPP, Ribeiro AH, Tomaz SL, Merkel CA, Costanzi-Strauss E, Strauss BE. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy [Internet]. Cancer Immunology, Immunotherapy. 2016 ; 65( 4): 371-382.[citado 2024 jun. 27 ] Available from: https://doi.org/10.1007/s00262-016-1807-8Vancouver
Medrano RF, Catani JPP, Ribeiro AH, Tomaz SL, Merkel CA, Costanzi-Strauss E, Strauss BE. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy [Internet]. Cancer Immunology, Immunotherapy. 2016 ; 65( 4): 371-382.[citado 2024 jun. 27 ] Available from: https://doi.org/10.1007/s00262-016-1807-8
